UBS Lowers the PT on Ambev S.A. (ABEV), Keeps a Neutral Rating

Ambev S.A. (NYSE:ABEV) is one of the Most Undervalued International Stocks According to Analysts. On August 20, UBS analyst Rodrigo Alcantara lowered the firm’s price target on Ambev S.A. (NYSE:ABEV) from $2.50 to $2.20, while keeping a Neutral rating on the stock.

The rating follows the company’s release of its fiscal second-quarter results for 2025. The company delivered mixed results with revenue reaching $3.59 billion, after growing 2.65% year-over-year, but missed consensus by $250.95 million. Management noted the company continued to execute its growth plan effectively despite tough market conditions. The revenue growth was driven by strong demand for its brands and a smart pricing strategy. This also improved the gross margins by 80 basis points. The company remains optimistic for the second half of the year.

Ambev S.A. (NYSE:ABEV) is a Brazilian company that produces and sells beer, soft drinks, and other beverages. It operates across the Americas, including countries in Latin America and Canada.

While we acknowledge the potential of ABEV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.